WO2000071567A3 - Fibroblast growth factor 13 - Google Patents

Fibroblast growth factor 13 Download PDF

Info

Publication number
WO2000071567A3
WO2000071567A3 PCT/US2000/040080 US0040080W WO0071567A3 WO 2000071567 A3 WO2000071567 A3 WO 2000071567A3 US 0040080 W US0040080 W US 0040080W WO 0071567 A3 WO0071567 A3 WO 0071567A3
Authority
WO
WIPO (PCT)
Prior art keywords
growth factor
fibroblast growth
human protein
protein
novel human
Prior art date
Application number
PCT/US2000/040080
Other languages
French (fr)
Other versions
WO2000071567A2 (en
Inventor
Robert Melder
Roxanne D Duan
Ralph Alderson
Craig A Rosen
John M Greene
Joachim R Gruber
Original Assignee
Human Genome Sciences Inc
Robert Melder
Roxanne D Duan
Ralph Alderson
Craig A Rosen
John M Greene
Joachim R Gruber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc, Robert Melder, Roxanne D Duan, Ralph Alderson, Craig A Rosen, John M Greene, Joachim R Gruber filed Critical Human Genome Sciences Inc
Priority to AU69514/00A priority Critical patent/AU6951400A/en
Publication of WO2000071567A2 publication Critical patent/WO2000071567A2/en
Publication of WO2000071567A3 publication Critical patent/WO2000071567A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/50—Fibroblast growth factors [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Abstract

The present invention relates to a novel human protein called Fibroblast Growth Factor 13, and isolated polynucleotides encoding this protein. Also provided are vectors, host cells, antibodies, and recombinant methods for producing this human protein. The invention further relates to diagnostic and therapeutic methods useful for diagnosing and treating disorders related to this novel human protein.
PCT/US2000/040080 1999-05-06 2000-05-04 Fibroblast growth factor 13 WO2000071567A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU69514/00A AU6951400A (en) 1999-05-06 2000-05-04 Fibroblast growth factor 13

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13292399P 1999-05-06 1999-05-06
US60/132,923 1999-05-06

Publications (2)

Publication Number Publication Date
WO2000071567A2 WO2000071567A2 (en) 2000-11-30
WO2000071567A3 true WO2000071567A3 (en) 2001-03-22

Family

ID=22456192

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/040080 WO2000071567A2 (en) 1999-05-06 2000-05-04 Fibroblast growth factor 13

Country Status (2)

Country Link
AU (1) AU6951400A (en)
WO (1) WO2000071567A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990022315A (en) * 1995-06-05 1999-03-25 벤슨 로버트 에이치. Fibroblast Growth Factor 13
TWI243826B (en) * 2001-07-19 2005-11-21 Akzo Nobel Nv Process for the preparation of peptides

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728546A (en) * 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
WO1998023749A1 (en) * 1996-11-27 1998-06-04 Human Genome Sciences, Inc. Fibroblast growth factor-13

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5728546A (en) * 1995-06-05 1998-03-17 Human Genome Sciences, Inc. Fibroblast growth factor 13
WO1998023749A1 (en) * 1996-11-27 1998-06-04 Human Genome Sciences, Inc. Fibroblast growth factor-13

Also Published As

Publication number Publication date
WO2000071567A2 (en) 2000-11-30
AU6951400A (en) 2000-12-12

Similar Documents

Publication Publication Date Title
EP1082433A4 (en) Interleukins-21 and 22
EP2189475A3 (en) Fibroblast growth factor-like polypeptides
WO2001058915A3 (en) Human g-protein chemokine receptor (ccr5) hdgnr10
EP1053245A4 (en) 45 human secreted proteins
WO1999060017A3 (en) Human tumour-derived polypeptide hormone phosphatonin
EP1093457B8 (en) Cytokine receptor common gamma chain like
WO2001032910A3 (en) 27 human secreted proteins
WO2001036432A3 (en) 18 human secreted proteins
WO1998045712A3 (en) 20 human secreted proteins
WO2001012776A3 (en) 18 human secreted proteins
WO2001034768A3 (en) 15 human secreted proteins
WO2000017222A8 (en) 31 human secreted proteins
WO2000073323A3 (en) Adam polynucleotides and polypeptides
WO2000077026A8 (en) 49 human secreted proteins
WO2001008635A3 (en) Calcium channel transport polynucleotides, polypeptides, and antibodies
WO2000063230A3 (en) 49 human secreted proteins
EP1042342A4 (en) 53 human secreted proteins
WO2001032878A3 (en) A novel polypeptide hormone phosphatonin
EP1443055A3 (en) Interleukins-21 and 22
WO2000071567A3 (en) Fibroblast growth factor 13
WO2001012775A3 (en) 25 human secreted proteins
WO2000042165A3 (en) Bone marrow-specific protein
WO2000043495A3 (en) 33 human secreted proteins
WO2002028873A3 (en) Transcription factor polynucleotides, polypeptides, antibodies, and methods based thereon
WO2000061596A8 (en) 50 human secreted proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP